Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite (ICU) Using Citrate- vs Acetate-based Dialysate

NCT05936710 is registered in ClinicalTrials.gov with Centre Hospitalier de Bethune as lead sponsor.

NCT NCT05936710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05936710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Hemodynamic Tolerance of Intermittent Hemodialysis Sessions in Intensive Care Unite (ICU) Using Citrate- vs Acetate-based Dialysate
Lead sponsor
Centre Hospitalier de Bethune
Phase
Not applicable
Overall status
Recruiting
Start date
December 7, 2023
Completion date
July 31, 2027
Enrollment
48 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

intradialytic hypotension